Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,480.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,550.00p
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 32,045
  • Market Cap: £1,637.71m
  • RiskGrade: 128
Select chart: 1 month | 3 month | 6 month | 1 year
 

Current

1 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 671.96 76.77 76.72p 32.3 1.9 +17% 32.84p 0.0%
30-Jun-26 699.01 87.08 89.20p 27.8 1.7 +16% 34.66p 0.0%
30-Jun-27 731.77 95.26 102.38p 24.2 1.6 +15% 36.87p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2026 699 n/a 699 704 701 720
30-Jun-2027 732 n/a 732 742 738 n/a
 
Earnings
30-Jun-2026 89.20p n/a 89.20p 89.07p 88.62p 96.12p
30-Jun-2027 102.38p n/a 102.38p 100.79p 101.49p n/a
 
Dividend
30-Jun-2026 34.66p n/a 34.66p 34.60p 34.66p 40.39p
30-Jun-2027 36.87p n/a 36.87p 35.36p 36.06p n/a
 
Recommendations
Strong Buy 6 0 6 6 5 5
Buy 2 0 2 3 2 2
Neutral 0 0 1 1 1 0
Sell 1 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 9 0 9 10 8 7
 
Average Rec 8.61 n/a 8.89 8.75 8.75 9.29

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,480.00p
Change Today -30.00p
% Change -1.20 %
52 Week High 2,550.00p
52 Week Low 1,424.00p
Volume 32,045
Shares Issued 66.04m
Market Cap £1,637.71m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.52% below the market average92.52% below the market average92.52% below the market average92.52% below the market average92.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Income
98.61% below the market average98.61% below the market average98.61% below the market average98.61% below the market average98.61% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average91.97% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 30-Jul-2025

Time Volume / Share Price
16:36 914 @ 2,479.99p
16:35 15,575 @ 2,480.00p
16:35 138 @ 2,480.00p
16:35 144 @ 2,480.00p
16:35 240 @ 2,480.00p

Genus Key Personnel

CEO Jorgen Kokke

Top of Page